Søgeresultater - Jonathan Werner
- Showing 1 - 2 results of 2
-
1
<i>In Vitro</i> and <i>In Vivo</i> Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models af Paul E. Hughes, Karen Rex, Sean Caenepeel, Yajing Yang, Yihong Zhang, Martin A. Broome, Hue T. Kha, Teresa L. Burgess, Benny Amore, Paula Kaplan‐Lefko, Jodi Moriguchi, Jonathan Werner, Michael A. Damore, D. N. Baker, Deborah M. Choquette, Jean-Christophe Harmange, Robert Radinsky, Richard Kendall, Isabelle Dussault, Angela Coxon
Udgivet 2016Artigo -
2
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer af Michael J. Giffin, Keegan S. Cooke, Edward K. Lobenhofer, Juan Estrada, Jinghui Zhan, Petra Deegen, Melissa Thomas, Christopher M. Murawsky, Jonathan Werner, Siyuan Liu, Fei Lee, Oliver Homann, Matthias Friedrich, Joshua T. Pearson, Tobias Raum, Yajing Yang, Sean Caenepeel, Jennitte Stevens, Pedro J. Beltran, Jude Canon, Angela Coxon, Julie M. Bailis, Paul E. Hughes
Udgivet 2020Artigo
Søgeredskaber:
Relaterede emner
Biochemistry
Cancer research
Chemistry
Biology
Cell
Cell biology
Cell culture
Cell growth
Genetics
Immune system
Immunology
In vitro
In vivo
Internal medicine
Kinase
Ligand (biochemistry)
Lung cancer
MAPK/ERK pathway
Mechanism of action
Medicine
Oncology
PI3K/AKT/mTOR pathway
Pharmacology
Receptor
Receptor tyrosine kinase
Signal transduction
Small molecule
T cell
Tyrosine kinase